Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5795554 | 6675659 | F | 5795554-7 | 20080419 | 20080618 | 20080630 | EXP | PHHY2008JP08056 | NOVARTIS PHARMACEUTICALS CORP. | F | Y | 49 | KG | 20080630 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5795554 | 1010112655 | PS | LOCHOL | 2 | ORAL | 20 MG, QD | 20261 | ||||
5795554 | 1010112656 | C | DIOVAN | 1 | ORAL | 160 MG, UNK | |||||
5795554 | 1010112657 | C | ALDACTONE | 1 | ORAL | 25 MG, UNK |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5795554 | 1010112655 | HYPERCHOLESTEROLAEMIA |
5795554 | 1010112656 | HYPERTENSION |
5795554 | 1010112657 | HYPERTENSION |
Outcome of event
Event ID | OUTC COD |
---|---|
5795554 | OT |
Reactions reported
Event ID | PT |
---|---|
5795554 | ALANINE AMINOTRANSFERASE INCREASED |
5795554 | ASPARTATE AMINOTRANSFERASE INCREASED |
5795554 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
5795554 | GASTRIC POLYPS |
5795554 | HEPATIC FUNCTION ABNORMAL |
5795554 | HIATUS HERNIA |
5795554 | LYMPHADENOPATHY |
5795554 | MALAISE |
5795554 | MASS |
5795554 | PYREXIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5795554 | 1010112655 | 20080409 | 20080424 | 16 | DAY |
5795554 | 1010112656 | 20050704 | |||
5795554 | 1010112657 | 20051121 |